Market revenue in 2020 | USD 29,188.8 million |
Market revenue in 2028 | USD 105,082.1 million |
Growth rate | 17.4% (CAGR from 2020 to 2028) |
Largest segment | (crispr)/cas9 |
Fastest growing segment | (CRISPR)/Cas9 |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
Key market players worldwide | Thermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.
(crispr)/cas9 was the largest segment with a revenue share of 42.8% in 2020. Horizon Databook has segmented the China mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.
China accounted for a significant revenue share in Asia Pacific’s market. Significant contribution from the country can be attributed to the extensive research being carried out in the country along with rapid adoption of geneediting techniques as treatment options.
However, in March 2019, the Chinese health ministry introduced draft regulations following CRISPR-baby controversy. These regulations have restricted the use of gene-editing technologies for human applications.
The draft also includes 7 penalties for breaking the rule. Such undertakings can impede the usage of gene-editing technologies in the country, consequently restraining the mutation detection kits market. On the other hand, companies such as Merck KGaA are expanding their presence in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the China mutation detection kits in genome editing market , including forecasts for subscribers. This country databook contains high-level insights into China mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account